SIRT1 and diabetes mellitus: Although our preliminary study shows no significant correlation between plasma levels of SIRT1 and fasting glucose in schizophrenia patients treated with SGAs, many existing studies to date revealed that reduced SIRT1 is involved in the pathogenesis of hyperglycemia and diabetes (46–49).